Related Experiment Video

Updated: Jul 9, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

[Optimizing antithrombotic therapy in non-ST-elevation acute coronary syndrome]

Javier Ortigosa1

  • 1Servicio de Cardiología, Hospital Puerta de Hierro, Madrid, España. fjortigosa1@hotmail.com

Revista Espanola De Cardiologia
|February 7, 2008
PubMed

Insights

This review summarizes recent antithrombotic therapy advancements for non-ST-segment elevation acute coronary syndromes, focusing on clopidogrel pretreatment, antiplatelet resistance, and novel anticoagulant roles.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Acute coronary syndromes (ACS) stem from atherothrombosis, involving plaque rupture and thrombus formation.
  • Non-ST-segment elevation ACS includes myocardial infarction and unstable angina.

Purpose of the Study:

  • To review the latest developments in antithrombotic treatments for non-ST-segment elevation ACS.
  • To address key clinical questions regarding antithrombotic strategies.

Main Methods:

  • Literature review focusing on advancements within the past year.
  • Analysis of four critical areas in antithrombotic therapy.

Main Results:

  • Discusses pretreatment with clopidogrel before percutaneous coronary intervention.
  • Examines challenges of antiplatelet resistance.
  • Evaluates glycoprotein IIb/IIIa inhibitor use in clopidogrel-pretreated patients.
  • Assesses the roles of bivalirudine and fondaparinux.

Conclusions:

  • Antithrombotic therapy for non-ST-segment elevation ACS is evolving.
  • Optimal strategies require careful consideration of patient factors and drug interactions.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...